LY2216684
LY2216684 is a pharmaceutical drug with 25 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
16
Early Stage
4
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
25 of 25 finished
0.0%
0 ended early
0
trials recruiting
25
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of LY2216684 and Theophylline in Healthy Subjects
A Study of LY2216684 in Healthy Participants
A Study of the Effect of LY2216684 on Lorazepam
A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.
A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol
Clinical Trials (25)
A Study of LY2216684 and Theophylline in Healthy Subjects
A Study of LY2216684 in Healthy Participants
A Study of the Effect of LY2216684 on Lorazepam
A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.
A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol
A Study of LY2216684 and Warfarin in Healthy Subjects
A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline
A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects
A Study to Evaluate the Effect of Food on LY2216684
A Study to Evaluate the Effect of Genotype on LY2216684
A Study of LY2216684 in Participants With Major Depression Disorder
A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
A Study of LY2216684 in Healthy Females
A Study of LY2216684 and Digoxin in Healthy Subjects
A Study of LY2216684 in Participants With Impaired Hepatic Function
A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel
A Study to Evaluate the Effect of Clarithromycin on LY2216684
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Study for Participants With Major Depression
A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 25